14542 Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices 

TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1

21 CFR Part Number of 

recordkeepers 

Number of 

records per 

recordkeeper 

Total annual 

records 

Average 

burden per 

recordkeeping 

Total hours 2

Record retention, 801.150(a)(2) ................................. 218 37.5 8,175 0.50 (30 minutes) .... 4088 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2 Rounded to the nearest hour. 

TABLE 2—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1

21 CFR Part Number of 

respondents 

Number of 

disclosures 

per 

respondent 

Total annual 

disclosures 

Average 

burden per 

disclosure 

Total hours 

Agreement and labeling requirements, 801.150(e) ............. 218 37.5 8,175 4 32,700 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Our estimated burden for the 

information collection reflects an 

overall increase of 27,778 hours and a 

corresponding increase of 6,175 

responses/records. We attribute this 

adjustment to an increase in the number 

of submissions we received over the last 

few years. 

Dated: March 2, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–05402 Filed 3–14–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health (NIH) 

National Institute of Mental Health 

(NIMH); Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Autism 

Coordinating Committee. 

The purpose of the IACC meeting is 

to discuss business, agency updates, and 

issues related to autism spectrum 

disorder (ASD) research and services 

activities. The meeting will be held as 

a virtual meeting and is open to the 

public. Individuals who plan to view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations to view the meeting 

should notify the Contact Person listed 

below at least seven (7) business days in 

advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocast 

website (http://videocast.nih.gov/). 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Date: April 13–14, 2022. 

Time: Wednesday, April 13, 2022, 1:00 

p.m. to 5:00 p.m. ET. 

Meeting Access: Wednesday, April 13, 

2022, https://videocast.nih.gov/watch=44688. 

Time: Thursday, April 14, 2022, 1:00 p.m. 

to 5:00 p.m. ET. 

Meeting Access: Thursday, April 14, 2022, 

https://videocast.nih.gov/watch=44690 

Agenda: To discuss business, updates, and 

issues related to ASD research and services 

activities. 

Cost: The meeting is free and open to the 

public. 

Registration: A registration web link will 

be posted on the IACC website 

(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. 

Deadlines: Written/Virtual Public 

Comment Due Date: Friday, April 1, 2022, by 

5:00 p.m. ET, Public Comment Guidelines, 

For public comment instructions, see below. 

Contact Person: Ms. Rebecca Martin, Office 

of Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9669, Phone: 301–435–0886, email: 

IACCPublicInquiries@mail.nih.gov. 

Public Comments 

The IACC welcomes public comments 

from members of the autism community 

and asks the community to review and 

adhere to its Public Comment 

Guidelines. In the 2016–2017 IACC 

Strategic Plan, the IACC listed the 

‘‘Spirit of Collaboration’’ as one of its 

core values, stating that, ‘‘We will treat 

others with respect, listen with open 

minds to the diverse views of people on 

the autism spectrum and their families, 

thoughtfully consider community input, 

and foster discussions where 

participants can comfortably offer 

opposing opinions.’’ In keeping with 

this core value, the IACC and the NIMH 

Office of Autism Research Coordination 

(OARC) ask that members of the public 

who provide public comments or 

participate in meetings of the IACC also 

seek to treat others with respect and 

consideration in their communications 

and actions, even when discussing 

issues of genuine concern or 

disagreement. 

As the IACC will be updating its 

Strategic Plan, comments related to 

issues that the community would like to 

see highlighted in the new IACC 

Strategic Plan are welcome. Comments 

may be submitted in writing via email 

to IACCPublicInquiries@mail.nih.gov or 

using the web form at: https://

iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 

p.m. ET on Friday, April 1, 2022. A 

limited number of slots are available for 

individuals to provide a 2–3-minute 

summary or excerpt of their written 

comment to the Committee live during 

the virtual meeting using the virtual 

platform. For those interested in that 

opportunity, please indicate ‘‘Interested 

in providing virtual comment’’ in your 

written submission, along with your 

name, address, email, phone number, 

and professional/organizational 

affiliation so that OARC staff can 

contact you if a slot is available for you 

to provide a summary or excerpt of your 

comment via the virtual platform during 

the meeting. For any given meeting, 

priority for live virtual comment slots 

will be given to those who have not 

previously provided live virtual 

comments in the current calendar year. 

This will help ensure that as many 

individuals as possible have an 

opportunity to share comments. 

Commenters going over their allotted 3- 

minute slot may be asked to conclude 

immediately in order to allow other 

comments and the rest of the meeting to 

proceed on schedule. 

Public comments received by 5:00 

p.m. ET on Friday, April 1, 2022, will 

be provided to the Committee prior to 

the meeting for their consideration. Any 

written comments received after 5:00 

p.m. ET, April 1, 2022, may be provided 

to the Committee either before or after 


khammond on DSKJM1Z7X2PROD with NOTICES

I I I I 

I I I I 
Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices 14543 

the meeting, depending on the volume 

of comments received and the time 

required to process them in accordance 

with privacy regulations and other 

applicable Federal policies. The 

Committee is not able to individually 

respond to comments. All public 

comments become part of the public 

record. Attachments of copyrighted 

publications are not permitted, but web 

links or citations for any copyrighted 

works cited may be provided. For public 

comment guidelines, see: https://

iacc.hhs.gov/meetings/publiccomments/guidelines/. 

Technical Issues 

If you experience any technical 

problems with the webcast please email 

IACCPublicInquiries@mail.nih.gov. 

Meeting schedule subject to change. 

Disability Accommodations 

All IACC Full Committee Meetings 

provide Closed Captioning through the 

NIH videocast website. Individuals 

whose full participation in the meeting 

will require special accommodations 

(e.g., sign language or interpreting 

services, etc.) must submit a request to 

the Contact Person listed on the notice 

at least seven (7) business days prior to 

the meeting. Such requests should 

include a detailed description of the 

accommodation needed and a way for 

the IACC to contact the requester if 

more information is needed to fill the 

request. Special requests should be 

made at least seven (7) business days 

prior to the meeting; last-minute 

requests may be made but may not be 

possible to accommodate. 

More Information 

Information about the IACC is 

available on the website: http://

www.iacc.hhs.gov. 

Dated: March 10, 2022. 

Melanie Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05468 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Neurological Disorders and Stroke 

Council. 

The meeting will be open to the 

public as indicated below. Individuals 

who plan to participate and need 

special assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: May 18–19, 2022. 

Open: May 18, 2022, 1:00 p.m. to 5:30 p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Director, Division of 

Extramural Activities; Administrative and 

Program Developments; and Overview of the 

NINDS Intramural Program. 

Open session will be videocast from this 

link: https://videocast.nih.gov/. 

Closed: May 19, 2022, 1:00 p.m. to 5:00 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Closed: May 19, 2022, 5:00 p.m. to 5:30 

p.m. 

Agenda: To review and evaluate the 

Division of Intramural Research Board of 

Scientific Counselors’ Reports. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Rockville, MD 20852 (Virtual Meeting). 

Contact Person: Robert Finkelstein, Ph.D., 

Director of Extramural Research, National 

Institute of Neurological Disorders and 

Stroke, NIH, 6001 Executive Blvd., Suite 

3309, MSC 9531, Bethesda, MD 20892, (301) 

496–9248, finkelsr@ninds.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice at 

least 10 days in advance of the meeting. 

The statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.ninds.nih.gov, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: March 9, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05465 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for the 

treatment of cancer. The outcome of the 

evaluation will provide information to 

internal NCI committees that will 

decide whether NCI should support 

requests and make available contract 

resources for development of the 

potential therapeutic to improve the 

treatment of various forms of cancer. 

The research proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; FEB2022 

Cycle 40 NExT SEP Committee Meeting. 

Date: April 18, 2022. 

Time: 9:00 a.m. to 3:00 p.m. 

Agenda: To evaluate the NCI Experimental 

Therapeutics Program Portfolio. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Room 3A44, 

Bethesda, Maryland 20892 (WebEx Meeting). 

Contact Persons: Barbara Mroczkowski, 

Ph.D., Executive Secretary, Discovery 

Experimental Therapeutics Program, 

National Cancer Institute, NIH, 31 Center 

Drive, Room 3A44, Bethesda, MD 20817, 

(301) 496–4291, mroczkoskib@mail.nih.gov. 

Toby Hecht, Ph.D., Executive Secretary, 

Development Experimental Therapeutics 

Program, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 3W110, 

Rockville, MD 20850, (240) 276–5683, 

toby.hecht2@nih.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES